Aug 29, 2007 by Brian LawlerAdolor Stays in the RingIt takes another run at getting FDA approval for its lead drug.
Aug 27, 2007 by Brian LawlerCephalon Makes A DealThe newest drug in its cabinet is expected to hit the U.S. market in the fourth quarter.
Aug 27, 2007 by Brian LawlerNeurochem Down for the Count?Its Alzheimer's treatment flops in testing, on the heels of FDA disapproval of another Neurochem drug.
Aug 27, 2007 by Brian LawlerRound 2 for GenentechLearn a lesson or two from the drugmaker's dance with the FDA.
Aug 24, 2007 by Brian LawlerFlamel Under FireStocks fall when study fails to show drug's superiority.
Aug 24, 2007 by Brian LawlerExelixis Gets Marching OrdersExelixis' partner requests an early review of its No. 2 drug.
Aug 23, 2007 by Brian LawlerMyriad, Meet OprahThe pharmaceutical announces Q4 results and a new ad campaign.
Aug 22, 2007 by Brian LawlerA Smaller Slice of the Pie at EncysiveThe small company raises more cash as it struggles to get approval for a blood pressure drug.
Aug 21, 2007 by Brian LawlerChange of Pace at PDLShares rise after the CEO announces his resignation.
Aug 20, 2007 by Brian LawlerAre These Perfect Pharma Acquisitions?Weighing recent drug-industry deals' odds of success.
Aug 16, 2007 by Brian LawlerCounting the Ways I Love Your Free CashInvestors are not appreciating Gilead's potential for growing free cash flow.
Aug 15, 2007 by Brian LawlerCall for Change at TrimerisA shareholder group criticizes its spending on research. What's the motive?
Aug 14, 2007 by Brian LawlerAlexza's AnnouncementAlexza announces the expansion of its drug pipeline.
Aug 10, 2007 by Brian LawlerViroPharma Whacked by DataShares of ViroPharma fall after safety issues come to light with one of its drugs.
Aug 10, 2007 by Brian LawlerGPC Picking Up the PiecesThe pharmaceutical regroups, awaiting more data on a crucial drug candidate.
Aug 9, 2007 by Brian LawlerDepomed Is DistressedDepomed announces its second-quarter financial results.
Aug 9, 2007 by Brian LawlerBioMarin Gets BusyBioMarin announces its second-quarter financial results.
Aug 8, 2007 by Brian LawlerArray's Bright PipelineArray BioPharma announces its goals for the months ahead.
Aug 8, 2007 by Brian LawlerDendreon Plods AlongThe turbulent drug developer releases its quarterly financial results.
